Ramelteon 8 mg/1 TABLET
Micro Labs Limited
FDA Drug Information
Indications & Usage
1 INDICATIONS AND USAGE Ramelteon tablets are indicated for the treatment of insomnia characterized by difficulty with sleep onset. The clinical trials performed in support of efficacy were up to six months in duration. The final formal assessments of sleep latency were performed after two days of treatment during the crossover study (elderly only), at five weeks in the six week studies (adults and elderly), and at the end of the six month study (adults and elderly) [see Clinical Studies (14)].…
Source: FDA. For professional use only. Not a substitute for prescribing information.
Other Ramelteon NDC Codes
Wholesale and compliance resources
Order NDC 42571-0375-30 at Wholesale
Create a free Premier Pharma account to unlock live wholesale pricing and place orders with same-day fulfillment and full DSCSA T2 documentation (TI + TS).